Senzar Asset Management as of March 31, 2018
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 31 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
AstraZeneca (AZN) | 8.4 | $27M | 758k | 34.97 | |
EXACT Sciences Corporation (EXAS) | 6.9 | $22M | 542k | 40.35 | |
Regeneron Pharmaceuticals (REGN) | 6.7 | $21M | 62k | 344.35 | |
Sanofi-Aventis SA (SNY) | 6.5 | $21M | 511k | 40.08 | |
Mylan Nv | 6.4 | $20M | 494k | 41.15 | |
Allergan | 4.9 | $16M | 92k | 168.29 | |
Pfizer (PFE) | 4.9 | $16M | 435k | 35.49 | |
CIGNA Corporation | 4.9 | $15M | 92k | 167.74 | |
Merck & Co (MRK) | 4.8 | $15M | 282k | 54.47 | |
Medtronic (MDT) | 4.0 | $13M | 160k | 80.22 | |
Alder Biopharmaceuticals | 3.3 | $11M | 823k | 12.71 | |
Novartis (NVS) | 3.2 | $10M | 127k | 80.85 | |
Amgen (AMGN) | 3.2 | $10M | 59k | 170.47 | |
Ironwood Pharmaceuticals (IRWD) | 3.2 | $10M | 650k | 15.42 | |
Dr. Reddy's Laboratories (RDY) | 3.0 | $9.6M | 295k | 32.66 | |
CVS Caremark Corporation (CVS) | 2.4 | $7.5M | 121k | 62.21 | |
Aetna | 2.3 | $7.4M | 44k | 168.75 | |
Tg Therapeutics (TGTX) | 2.1 | $6.8M | 476k | 14.20 | |
MiMedx (MDXG) | 2.0 | $6.3M | 902k | 6.97 | |
Endologix | 1.8 | $5.6M | 1.3M | 4.23 | |
United Therapeutics Corporation (UTHR) | 1.7 | $5.3M | 47k | 112.22 | |
Bristol Myers Squibb (BMY) | 1.6 | $5.2M | 82k | 63.24 | |
NxStage Medical | 1.6 | $5.2M | 209k | 24.81 | |
Sientra | 1.6 | $5.1M | 529k | 9.66 | |
Arena Pharmaceuticals | 1.6 | $5.0M | 128k | 39.50 | |
AmerisourceBergen (COR) | 1.6 | $5.0M | 58k | 86.22 | |
Concert Pharmaceuticals I equity | 1.4 | $4.6M | 199k | 22.94 | |
Theravance Biopharma (TBPH) | 1.4 | $4.6M | 188k | 24.25 | |
Aerie Pharmaceuticals | 1.2 | $3.8M | 71k | 54.25 | |
Anaptysbio Inc Common (ANAB) | 0.8 | $2.6M | 25k | 104.07 | |
Protagonist Therapeutics (PTGX) | 0.5 | $1.5M | 176k | 8.59 |